Lindbrook Capital, LLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PULMONX CORP
ValueSharesWeighting
Q1 2024$3,856
-27.3%
4160.0%0.00%
-100.0%
Q4 2023$5,304
+39.1%
416
+12.7%
0.00%
Q3 2023$3,812
-21.2%
3690.0%0.00%
-100.0%
Q2 2023$4,838
+17.3%
3690.0%0.00%
Q1 2023$4,125
+32.6%
3690.0%0.00%
Q4 2022$3,111
+3.7%
369
+85.4%
0.00%
-100.0%
Q3 2022$3,000199
+1226.7%
0.00%
Q2 2022$015
-11.8%
0.00%
Q1 2022$0170.00%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders